Get the Stockscreener App
4.23
7.54%
-0.345
After Hours:
4.30
0.07
+1.65%
Personalis Inc Stock (PSNL) Latest News
Personalis Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates - MSN
Personalis Inc (NASDAQ: PSNL) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
Personalis (PSNL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Personalis Inc (PSNL) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle
Personalis (PSNL) Projected to Post Earnings on Wednesday - Defense World
Precision Oncology Leader Personalis Unveils Next Steps at Major Healthcare Conference - StockTitan
PSNLPersonalis Latest Stock News & Market Updates - StockTitan
297,889 Shares in Personalis, Inc. (NASDAQ:PSNL) Bought by abrdn plc - MarketBeat
Exciting Technology At Personalis, But Profitability Eludes Them (NASDAQ:PSNL) - Seeking Alpha
SG Americas Securities LLC Buys New Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Sumitomo Mitsui Trust Group Inc. Sells 59,295 Shares of Personalis, Inc. (NASDAQ:PSNL) - MarketBeat
Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Cancer Genomics Pioneer Personalis Unveils Q4 Earnings DateKey Details Inside - StockTitan
Understanding the Risks of Investing in Personalis Inc (PSNL) - Knox Daily
Wall Street analysts’ outlook for Personalis Inc (PSNL) - SETE News
Should You Expect A Quick Recovery From Personalis Inc (NASDAQ: PSNL) After -35.08% Decline From High? - Marketing Sentinel
BlackRock, Inc.'s Strategic Acquisition of Personalis Inc. Shares - GuruFocus.com
Personalis Inc (PSNL) is a good investment, but the stock may be overvalued - US Post News
Needham analysts upgrades a Buy rating for Personalis Inc (PSNL) - Knox Daily
Personalis, Inc. (NASDAQ:PSNL) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
FY2024 EPS Estimates for Personalis Lowered by HC Wainwright - MarketBeat
Analysts Issue Forecasts for Personalis FY2029 Earnings - MarketBeat
FY2024 EPS Estimates for Personalis Reduced by HC Wainwright - Defense World
Personalis price target lowered to $8 from $11 at H.C. Wainwright - MSN
Brokers Set Expectations for Personalis FY2029 Earnings - Defense World
Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Marketscreener.com
Precision Oncology Leader Personalis Takes Center Stage at Major Healthcare Summit - StockTitan
Personalis stock price target cut to $8 by H.C. Wainwright - MSN
Personalis (NASDAQ:PSNL) Given New $8.00 Price Target at HC Wainwright - Defense World
Personalis Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) - Benzinga
HC Wainwright Cuts Personalis (NASDAQ:PSNL) Price Target to $8.00 - MarketBeat
Personalis (PSNL) Upgraded to Buy: Here's Why - Yahoo Finance
Personalis, Inc. (NASDAQ:PSNL) Stock Position Increased by Barclays PLC - Defense World
Researchers find ctDNA test predicts lung cancer outcomes in study - Yahoo Finance
New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer - sharewise
Catherine Wood's Strategic Acquisition of Personalis Inc Shares - GuruFocus.com
Personalis (NASDAQ:PSNL) Stock Price Expected to Rise, Lake Street Capital Analyst Says - Defense World
Personalis stock target lifted, retains buy on impressive performance By Investing.com - Investing.com Canada
Personalis (NASDAQ:PSNL) Price Target Raised to $9.00 - MarketBeat
Personalis stock target lifted, retains buy on impressive performance - Investing.com India
Personalis (NASDAQ:PSNL) Earns Buy Rating from HC Wainwright - MarketBeat
Needham & Company LLC Reaffirms "Buy" Rating for Personalis (NASDAQ:PSNL) - MarketBeat
1.50%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):